REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Clinical trials for REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

Sign up with your email to follow new studies for REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids: drug trial aims to shield transplant patients from dangerous viruses

Disease control Recruiting now

This study is testing if a drug called letermovir can prevent serious viral infections in children after they receive a stem cell transplant for certain severe, EBV-related blood diseases. It will involve 80 children under 18 who are at high risk for these infections. The main go…

Matched conditions: REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Phase: NA • Sponsor: Beijing Children's Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Get alerted when new REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

New hope for kids: drug trial aims to shield transplant patients from dangerous viruses